Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$94.2K
16K shares
What this filing means
BORMANN-KENNEDY BARBARA-JEAN ANNE plans to sell 16K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $94.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/4/2026ACC: 0001950047-26-005661
Director
Since Oct 2021
16K
Shares to sell
$94.2K
Approx. market value
16K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/3/2026
16KTotal acquired16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/3/2026 | Restricted Stock Units N/A | 16K | — |
| Total | 16K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
16K
Market value
$94.2K
6/4/2026
Total
Units
16K
Value
$94.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/4/2026 | 16K | $94.2K | NASDAQ | Planned |
| Total | 16K | $94.2K | ||